UK GLP-1 Surge- What Clinics Must Know: Recent data from Grand View Research shows that GLP-1 users in the UK have jumped from 2.3% in March 2024 to 4.1% today The UK weight-loss GLP-1 market is projected to reach US$715 million by 2030, growing at a 17.7% CAGR from 2025 to 2030
One point is where it seems to act
If youre struggling with chronic skin conditions like psoriasis, rosacea or eczema: A dermatologist or other healthcare professional can walk you through topical and systemic treatments, including prescription topicals, low-dose antibiotics for rosacea, or biologics for more severe eczema
Both semaglutide and tirzepatide commonly have gastrointestinal side effects, such as: Nausea Vomiting Diarrhea Stomach pains However, you may be more likely to have differences in the prevalence of effects like constipation and acid reflux if taking semaglutide
At 40, other symptoms of low T cropped up, such as poor sleep, low energy, irritability, and weight gain
It is not a generic or substitute, it is the same molecule, tirzepatide, formulated and dispensed under medical supervision